Cita APA

de Herreros, M., Jiménez, N., Rodríguez-Carunchio, L., Lillo, E., Marín-Aguilera, M., Ferrer-Mileo, L., . . . Mellado, B. (2024). Prognostic Expression Signature of RB1, PTEN, and TP53 Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors.

Citación estilo Chicago

de Herreros, MG, et al. Prognostic Expression Signature of RB1, PTEN, and TP53 Genes in Patients With Metastatic Hormone-sensitive Prostate Cancer Treated With Androgen Receptor Pathway Inhibitors. 2024.

Cita MLA

de Herreros, MG, et al. Prognostic Expression Signature of RB1, PTEN, and TP53 Genes in Patients With Metastatic Hormone-sensitive Prostate Cancer Treated With Androgen Receptor Pathway Inhibitors. 2024.